What actinium costs

What does it cost, and how is it bought and sold?

There is no public market price. Producers sell actinium-225 by the millicurie, at prices set in quotes or contracts. The one public price that we found is 800 US dollars per millicurie. It is in a contract of about 2004 between a Russian institute and a US company3.

Last updated 14 October 2026.

Price

No exchange or price agency publishes a price for actinium. The US Department of Energy (DOE) sells actinium-225 in millicuries, a unit of radioactivity, not of mass1. Buyers ask for a quote through the National Isotope Development Center (NIDC) catalog2. The NIDC does not publish the quoted prices.

The one price that we found is in a contract that Isonics, a US company, filed with the US Securities and Exchange Commission. In it, the Institute for Physics and Power Engineering in Obninsk, Russia, sold actinium-225 to Isonics at 800 US dollars per millicurie3. The total value of the contract was 652,320 dollars3. These are dollars of about 2004, not adjusted for inflation. The contract states that the product was for analytical research and for medical use3.

A price per gram has little meaning, because nobody buys actinium-225 by the gram. The contract gives a specific activity of 58,000 curies per gram. From this, we calculate roughly 46 billion dollars per gram at that price (800 dollars × 1,000 millicuries × 58,000 curies)3.

Price history

We found no series of prices for actinium. With one contract price from about 2004, we cannot give a trend.

How it is traded

Actinium is not traded on an exchange. It moves under contracts between a few producers and their customers:

  • US national laboratories. The DOE sells actinium-225 made from thorium-229 every week. On its product sheet, the DOE tells buyers to order far in advance because supply is limited4. Actinium-225 from accelerators is available every three weeks1.
  • Europe. In 2018 NorthStar wrote that the Institute for Transuranium Elements (ITU) made a few hundred millicuries of actinium-225 a year. The ITU did not sell it and supplied it only to its collaborators5. The ITU is the Karlsruhe site of the Joint Research Centre of the European Commission.
  • Russia. The same review described shipments from Russia of a few millicuries, from sources that are largely unknown and sporadic5.
  • Companies. In 2024 TerraPower Isotopes said that it supplies actinium-225 to drug companies from weekly production runs6.
  • Actinium-227. Oak Ridge National Laboratory makes actinium-227 for Bayer under a 10-year contract with the DOE Isotope Program7.

Large drug companies have bought developers of actinium-225 drugs. In 2024 Bristol Myers Squibb paid about 4.1 billion dollars for RayzeBio8. In the same year AstraZeneca bought Fusion Pharmaceuticals for up to about 2.4 billion dollars9. These sums are for the companies and their drug candidates, not for the actinium.

Sources

  1. 1

    National Isotope Development Center, US Department of Energy Isotope Program, 2025. Actinium-225 (Accelerator-Produced) Product Information .

    Production route, actinium-227 content, availability and unit of sale of accelerator-made actinium-225.

    • Unit of Sale Millicuries
    • Routinely available every three weeks
  2. 2

    National Isotope Development Center, US Department of Energy Isotope Program, 2018. Isotope Routinely Available: Actinium-225 .

    Start of regular accelerator production in 2018, the Oak Ridge thorium-229 source, and ordering by quote.

    • Quotation requests for both accelerator-produced and Th-229-produced Ac-225 may be placed using the National Isotope Development Center’s (NIDC) online product catalog
  3. 3

    Isonics Corporation, filed with the US Securities and Exchange Commission, 2005. Contract No. 840/08624390 between SSC RF - IPPE and Isonics Corporation (Exhibit 10.1) , Sections 1 and 2, Supplements 1 and 2.

    Contract price of actinium-225 sold by the Russian Institute for Physics and Power Engineering to a US company, and its specific activity.

    • Actinium-225 isotope, 1 st phase (delivery of samples for testing) 800.00
    • The total value of the Contract is $652320.00
    • The products are intended for analytical research.
    • The product will be used in medical purpose.
    • Specific activity 58000 Ci/g
    • 800.00
  4. 4

    National Isotope Development Center, US Department of Energy Isotope Program, 2025. Actinium-225 (Thorium-229 Decay Product) Product Information .

    Availability and unit of sale of actinium-225 from thorium-229.

    • Routinely available (weekly); order far in advance due to limited supply
  5. 5

    James T. Harvey, NorthStar Medical Technologies, in Current Radiopharmaceuticals 11, 2018. NorthStar Perspectives for Actinium-225 Production at Commercial Scale .

    A company view of world supply, cost per millicurie, and the disposal of uranium-233 that held thorium-229.

    • produces a few hundred millicuries of actinium-225 annually. ITU does not market or sell this actinium-225 but provides it only to their
    • There have been various attempts to ship small amounts (few mCi) of actinium-225 from Russia but the actual sources are largely unknown and sporadic in availability
  6. 6

    World Nuclear News, 2024. TerraPower producing Ac-225 in commercial quantities .

    TerraPower Isotopes' announcement of commercial-scale production of actinium-225.

    • providing sustained access to highly pure Ac-225 to the global pharmaceutical community through weekly production runs
  7. 7

    US Department of Energy, Office of Science, Isotope R&D and Production, 2019. Improving Isotope Supply for a Cancer-Fighting Drug .

    Actinium-227 made at Oak Ridge from recovered radium-226 for Bayer's radium-223 drug, under a 10-year contract.

    • through a 10-year contract between the DOE Isotope Program and this firm, ORNL is producing actinium-227
  8. 8

    Bristol Myers Squibb, 2024. Bristol Myers Squibb Completes Acquisition of RayzeBio, Adding Differentiated Actinium-Based Radiopharmaceutical Platform .

    The purchase price of RayzeBio and its lead actinium-225 drug candidate. Read with Firecrawl.

    • for a purchase price of $62.50 per share in cash, or approximately $4.1 billion
  9. 9

    AstraZeneca, 2024. Acquisition of Fusion completed .

    The purchase of Fusion Pharmaceuticals and its actinium-based drug candidates.

    • Combined, the upfront payment and maximum potential contingent value payment, if achieved, represent a transaction value of approximately $2.4bn.